Table of Content

1 Executive Summary


2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions


3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19


4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry


5 Global Drug Modeling Software Market, By Deployment
5.1 Introduction
5.2 On-Premise
5.3 Cloud-Based


6 Global Drug Modeling Software Market, By Product
6.1 Introduction
6.2 Software
6.3 Database


7 Global Drug Modeling Software Market, By Application
7.1 Introduction
7.2 Drug Discovery and Development
7.3 Simulation Software
7.4 Disease Modeling
7.5 Predictive Analysis of Drug Targets
7.6 Computational Physiological Medicine
7.7 Cellular Simulation
7.8 Medical Imaging


8 Global Drug Modeling Software Market, By End User
8.1 Introduction
8.2 Research Institutes
8.3 Laboratory
8.4 Educational Institutes


9 Global Drug Modeling Software Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa


10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies


11 Company Profiling
11.1 Schrodinger, Inc.
11.2 Biognos Ab
11.3 Crown Bioscience Inc
11.4 Acellera Ltd
11.5 Dassault Systemes
11.6 Chemical Computing Group Ulc
11.7 Genedata Ag
11.8 Nimbus Therapeutics
11.9 Leadscope Inc
11.10 Compugen Ltd

List of Tables
Table 1 Global Drug Modeling Software Market Outlook, By Region (2019-2028) ($MN)
Table 2 Global Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
Table 3 Global Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
Table 4 Global Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
Table 5 Global Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
Table 6 Global Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
Table 7 Global Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
Table 8 Global Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
Table 9 Global Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 10 Global Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
Table 11 Global Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
Table 12 Global Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
Table 13 Global Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
Table 14 Global Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
Table 15 Global Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
Table 16 Global Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
Table 17 Global Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
Table 18 Global Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
Table 19 Global Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
Table 20 North America Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
Table 21 North America Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
Table 22 North America Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
Table 23 North America Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
Table 24 North America Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
Table 25 North America Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
Table 26 North America Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
Table 27 North America Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
Table 28 North America Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 29 North America Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
Table 30 North America Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
Table 31 North America Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
Table 32 North America Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
Table 33 North America Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
Table 34 North America Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
Table 35 North America Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
Table 36 North America Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
Table 37 North America Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
Table 38 North America Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
Table 39 Europe Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
Table 40 Europe Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
Table 41 Europe Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
Table 42 Europe Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
Table 43 Europe Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
Table 44 Europe Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
Table 45 Europe Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
Table 46 Europe Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
Table 47 Europe Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 48 Europe Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
Table 49 Europe Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
Table 50 Europe Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
Table 51 Europe Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
Table 52 Europe Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
Table 53 Europe Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
Table 54 Europe Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
Table 55 Europe Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
Table 56 Europe Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
Table 57 Europe Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
Table 58 Asia Pacific Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
Table 59 Asia Pacific Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
Table 60 Asia Pacific Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
Table 61 Asia Pacific Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
Table 62 Asia Pacific Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
Table 63 Asia Pacific Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
Table 64 Asia Pacific Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
Table 65 Asia Pacific Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
Table 66 Asia Pacific Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 67 Asia Pacific Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
Table 68 Asia Pacific Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
Table 69 Asia Pacific Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
Table 70 Asia Pacific Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
Table 71 Asia Pacific Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
Table 72 Asia Pacific Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
Table 73 Asia Pacific Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
Table 74 Asia Pacific Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
Table 75 Asia Pacific Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
Table 76 Asia Pacific Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
Table 77 South America Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
Table 78 South America Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
Table 79 South America Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
Table 80 South America Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
Table 81 South America Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
Table 82 South America Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
Table 83 South America Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
Table 84 South America Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
Table 85 South America Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 86 South America Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
Table 87 South America Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
Table 88 South America Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
Table 89 South America Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
Table 90 South America Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
Table 91 South America Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
Table 92 South America Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
Table 93 South America Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
Table 94 South America Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
Table 95 South America Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
Table 96 Middle East & Africa Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
Table 97 Middle East & Africa Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
Table 98 Middle East & Africa Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
Table 99 Middle East & Africa Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
Table 100 Middle East & Africa Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
Table 101 Middle East & Africa Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
Table 102 Middle East & Africa Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
Table 103 Middle East & Africa Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
Table 104 Middle East & Africa Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 105 Middle East & Africa Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
Table 106 Middle East & Africa Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
Table 107 Middle East & Africa Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
Table 108 Middle East & Africa Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
Table 109 Middle East & Africa Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
Table 110 Middle East & Africa Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
Table 111 Middle East & Africa Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
Table 112 Middle East & Africa Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
Table 113 Middle East & Africa Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
Table 114 Middle East & Africa Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)